|
1）小川佳宏. 肥満と自然炎症. 日薬理誌. 2011; 138: 178-81
|
|
|
|
2）Osborn O, Olefsky JM. The cellular and signaling networks linking the immune system and metabolism in disease. Nat Med. 2012; 18: 363-74
|
|
|
|
|
|
3）Reidy K, Kang HM, Hostetter T, et al. Molecular mechanisms of diabetic kidney disease. J Clin Invest. 2014; 124: 2333-40
|
|
|
|
|
|
4）Wada J, Makino H. Inflammation and the pathogenesis of diabetic nephropathy. Clin Sci. 2013; 124: 139-52
|
|
|
|
|
|
5）Kuwabara T, Mori K, Mukoyama M, et al. Exacerbation of diabetic nephropathy by hyperlipidaemia is mediated by Toll-like receptor 4 in mice. Diabetologia. 2012; 55: 2256-66
|
|
|
|
|
|
6）Kuwabara T, Mori K, Mukoyama M, et al. Macrophage-mediated glucolipotoxicity via myeloid-related protein 8/toll-like receptor 4 signaling in diabetic nephropathy. Clin Exp Nephrol. 2014; 18: 584-92
|
|
|
|
|
|
7）Navarro-Gonzalez JF, Mora-Fernandez C, Muros de Fuentes M, et al. Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy. Nat Rev Nephrol. 2011; 7: 327-40
|
|
|
|
|
|
8）Hasegawa G, Nakano K, Sawada M, et al. Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int. 1991; 40: 1007-12
|
|
|
|
|
|
9）Bohle A, Wehrmann M, Bogenschutz O, et al. The pathogenesis of chronic renal failure in diabetic nephropathy: Investigation of 488 cases of diabetic glomerulosclerosis. Pathol Res Pract. 1991; 187: 251-9
|
|
|
|
|
|
10）Wolkow PP, Niewczas MA, Perkins B, et al. Association of urinary inflammatory markers and renal decline in microalbuminuric type 1 diabetes. J Am Soc Nephrol. 2008; 19: 789-97
|
|
|
|
|
|
11）Vogl T, Tenbrock K, Ludwig S, et al. Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock. Nat Med. 2007; 13: 1042-9
|
|
|
|
|
|
12）Donato R, Cannon BR, Sorci G, et al. Functions of S100 proteins. Curr Mol Med. 2013; 13: 24-57
|
|
|
|
|
|
13）Rosin DL, Okusa MD. Dangers within: DAMP responses to damage and cell death in kidney disease. J Am Soc Nephrol. 2011; 22: 416-25
|
|
|
|
|
|
14）Soro-Paavonen A, Watson AMD, Li J, et al. Receptor for advanced glycation end products (RAGE) deficiency attenuates the development of atherosclerosis in diabetes. Diabetes. 2008; 57: 2461-9
|
|
|
|
|
|
15）Pepper RJ, Hamour S, Chavele KM, et al. Leukocyte and serum S100A8/S100A9 expression reflects disease activity in ANCA-associated vasculitis and glomerulonephritis. Kidney Int. 2013; 83: 1150-8
|
|
|
|
|
|
16）Heller F, Frischmann S, Grunbaum M, et al. Urinary calprotectin and the distinction between prerenal and intrinsic acute kidney injury. Clin J Am Soc Nephrol. 2011; 6: 2347-55
|
|
|
|
|
|
17）Dressing MC, Tammaro A, Pulskens WP, et al. The calcium-binding protein complex S100A8/A9 has a crucial role in controlling macrophage-mediated renal repair following ischemia/reperfusion. Kidney Int. 2014; doi: 10. 1038/ki. 2014. 216. [Epub ahead of print]
|
|
|
|
|
|
18）Kuwabara T, Mori K, Kasahara M, et al. Predictive significance of kidney myeloid-related protein 8 expression in patients with obesity- or type 2 diabetes-associated kidney diseases. PLoS One. 2014; 9: e88942
|
|
|
|
|
|
19）Lin M, Yiu WH, Wu HJ, et al. Toll-like receptor 4 promotes tubular inflammation in diabetic nephropathy. J Am Soc Nephrol. 2012; 23: 86-102
|
|
|
|
|
|
20）Prentki M, Joly E, El-Assaad W, et al. Malonyl-CoA signaling, lipid partitioning, and glucolipotoxicity: role in beta-cell adaptation and failure in the etiology of diabetes. Diabetes. 2002; 51: S405-13
|
|
|
|
|
|
21）Poitout V, Amyot J, Semache M, et al. Glucolipotoxicity of the pancreatic beta cell. Biochim Biophys Acta. 2010; 180: 289-98
|
|
|
|
|
|
22）Nagareddy PR, Kraakman M, Masters SL, et al. Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metab. 2014; 19: 821-35
|
|
|
|
|
|
23）Fontes G, Semache M, Hagman DK, et al. Involvement of Per-Arnt-Sim Kinase and extracellular-regulated kinases-1/2 in palmitate inhibition of insulin gene expression in pancreatic beta-cells. Diabetes. 2009; 58: 2048-58
|
|
|
|
|
|
24）Zador IZ, Hsieh CC, Papaconstantinou J. Renal CCAAT/enhancer-binding proteins in experimental diabetes mellitus. Nephron. 1998; 79: 312-6
|
|
|
|
|
|
25）Endoh Y, Chung YM, Clark IA, et al. IL-10-dependent S100A8 gene induction in monocytes/macrophages by double-stranded RNA. J Immunol. 2009; 182: 2258-68
|
|
|
|
|
|
26）Hirosumi J, Tuncman G, Chang L, et al. A central role of JNK in obesity and insulin resistance. Nature. 2002; 420: 333-6
|
|
|
|
|
|
27）Bachar E, Ariav Y, Ketzinel-Gilad M, et al. Glucose amplifies fatty acid-induced endoplasmic reticulum stress in pancreatic beta-cells via activation of mTORC1. PLoS One. 2009; 4: e4954
|
|
|
|
|
|
28）Pal D, Dasgupta S, Kundu R, et al. Fetuin-A acts as an endogenous ligand of TLR4 to promote lipid-induced insulin resistance. Nat Med. 2012; 18: 1279-85
|
|
|
|
|
|
29）Zhang MZ, Wang S, Yang S, et al. Role of blood pressure and the renin-angiotensin system in development of diabetic nephropathy (DN) in eNOS－/－ db/db mice. Am J Physiol Renal Physiol. 2012; 302: F433-8
|
|
|
|
|
|
30）Kamiyama M, Garner MK, Farragut KM, et al. Detailed localization of augmented angiotensinogen mRNA and protein in proximal tubule segments of diabetic kidneys in rats and humans. Int J Biol Sci. 2014; 10: 530-42
|
|
|
|
|
|
31）Mezzano S, Droguett A, Burgos ME, et al. Renin-angiotensin system activation and interstitial inflammation in human diabetic nephropathy. Kidney Int Suppl. 2003; 86: S64-70
|
|
|
|
|
|
32）Acres OW, Satou R, Navar G, et al. Contribution of a nuclear factor-κB binding site to human angiotensinogen promoter activity in renal proximal tubular cells. Hypertension. 2011; 57: 608-13
|
|
|
|
|
|
33）Daugherty A, Rateri DL, Lu H, et al. Hypercholesterolemia stimulates angiotensin peptide synthesis and contributes to atherosclerosis through the AT1A receptor. Circulation. 2004; 110: 3849-57
|
|
|
|
|
|
34）Burkhardt K, Schwarz S, Pan C, et al. Myeloid-related protein 8/14 complex describes microcirculatory alterations in patients with type 2 diabetes and nephropathy. Cardiovasc Diabetol. 2009; 8: 10
|
|
|
|
|
|
35）Hirata A, Kishida K, Nakatsuji H, et al. High serum S100A8/A9 levels and high cardiovascular complication rate in type 2 diabetics with ultrasonographic low carotid plaque density. Diabetes Res Clin Pract. 2012; 97: 82-90
|
|
|
|
|
|
36）Nagareddy PR, Murphy AJ, Stirzaker RA, et al. Hyperglycemia promotes myelopoiesis and impairs the resolution of atherosclerosis. Cell Metab. 2013; 17: 695-708
|
|
|
|
|
|
37）Jin Y, Sharma A, Carey C, et al. The expression of inflammatory genes is upregulated in peripheral blood of patients with type 1 diabetes. Diabetes Care. 2013; 36: 2794-802
|
|
|
|
|